Sidley was the first international law firm to establish a stand-alone, comprehensive food and drug regulatory practice in China. As an integral part of our Global Life Sciences practice, we bring our knowledge of industry practices in the U.S. and EU to each project in China and help develop global Standard Operating Procedures (SOPs) and benchmark best practices.
We assist Chinese drug and device regulatory agencies in training programs on a broad range of topics. Sidley is also the first law firm to have been honored with a Memorandum of Understanding (MOU) issued by the Shanghai Institute for Food and Drug Safety in January 2008, under which Sidley provides input in the formulation of new drug and device laws and sponsors annual drug safety seminars for international audiences.
More than 50 leading global pharmaceutical, biological, medical device and food manufacturers have turned to Sidley for life sciences regulatory advice in China. Our regulatory experience covers such areas as: